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ABSTRACT
Purpose Rapid revascularization in emergent large
vessel occlusion with endovascular embolectomy has
proven clinical beneﬁt. We sought to measure device–
clot interaction as a potential mechanism for efﬁcient
embolectomy.
Methods Two different radiopaque clot models were
injected to create a middle cerebral artery occlusion in a
patient-speciﬁc vascular phantom. A radiopaque stent
retriever was deployed within the clot by unsheathing
the device or a combination of unsheathing followed by
pushing the device (n=8/group). High-resolution cone
beam CT was performed immediately after device
deployment and repeated after 5 min. An image
processing pipeline was created to quantitatively
evaluate the volume of clot that integrates with the
stent, termed the clot integration factor (CIF).
Results The CIF was signiﬁcantly different for the two
deployment variations when the device engaged the
hard clot (p=0.041), but not the soft clot (p=0.764). In
the hard clot, CIF increased signiﬁcantly between post-
deployment and ﬁnal imaging datasets when using the
pushing technique (p=0.019), but not when using the
unsheathing technique (p=0.067). When we
investigated the effect of time on CIF in the different clot
models disregarding the technique, the CIF was
signiﬁcantly increased in the ﬁnal dataset relative to
the post-deployment dataset in both clot models
(p=0.004–0.007).
Conclusions This study demonstrates in an in vitro
system the beneﬁt of pushing the Trevo stent during
device delivery in hard clot to enhance integration.
Regardless of delivery technique, clot–device integration
increased in both clot models by waiting 5 min.
INTRODUCTION
Endovascular treatment of emergent large vessel
occlusion (ELVO) using a mechanical approach to
thrombectomy has proven clinical beneﬁt.1–5 As
such, research into the mechanics of the embolus
that occludes the artery is of fundamental import-
ance.6 7 Prior studies found that the performance
of endovascular ELVO treatment and the risk of
distal embolization depend on clot mechanics.8 9
Recently, thrombectomy with the Trevo stent
retriever using a technique that uses forward force
to push the device during deployment with spon-
taneous retraction of the microcatheter has been
described, rather than simply unsheathing the
device.10 This technique was associated with a
statistically higher rate of ﬁrst-pass success and
higher rates of modiﬁed treatment in cerebral ische-
mia (Thrombolysis In Cerebral Infarction (TICI) 3)
reperfusion compared with unsheathing only.
Currently, it is recommended in the instructions
for use of some stent retrievers that sufﬁcient time
is allotted—estimated at approximately 5 min—for
the clot to integrate into the device following
deployment. However, in actual clinical practice,
the interaction time between clot and device
ranges from 30 s to >5 min.9 11–13 Recently, early
loss of immediate reperfusion on angiography
during this wait period was found to be associated
with a statistically signiﬁcant increase in the rate of
successful recanalization versus cases with persist-
ent reperfusion.14 This ﬁnding suggests that clot
embedment into the device facilitates successful
thrombectomy.
In this study we measured the interaction
between the stent and the clot over time following
device deployment. We deﬁne the ‘clot integration
factor’ (CIF) as the amount of clot that migrates
into the inner volume of the expanded stent. In
brief, the CIF is the volume ratio of amount of clot
that has penetrated into the stent retriever (numer-
ator) to the total amount of clot forming the occlu-
sion (denominator). In addition, two stent
deployment methods (forward pressure on the
delivery wire after initial unsheathing vs continuous
unsheathing) were compared with a goal of achiev-
ing secure clot–device integration.
METHODS
In vitro model
We modiﬁed a previously described in vitro model.
Brieﬂy, a vascular model was used that included the
bilateral internal carotid arteries (ICA) and basilar
artery as inputs and the posterior cerebral arteries,
A2 and M2 branches as outputs (ﬁgure 1). The
model included the entire circle of Willis and was
manufactured as previously described.15 Flow
sensors (Transonic Systems, Ithaca, New York, USA)
measured the ICA, middle cerebral artery (MCA),
anterior cerebral artery (ACA) and basilar ﬂow and
pressure transducers (Validyne Engineering,
Northridge, California, USA) recorded the prox-
imal and distal MCA pressure. Hosecock compres-
sor clamps were used at each outlet to adjust
peripheral resistance to maintain physiologically
relevant pressure and ﬂow rates (eg, the average
MCA ﬂow was 133 mL/min). The working ﬂuid
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was maintained at 37°C. To create the ELVO model, two types
of clot were introduced into the ICA that migrated with the
ﬂow to reliably create an occlusion of the MCA. Hard inelastic
clot was generated by thrombin-induced clotting of bovine
blood (2.5 NIHU thrombin/mL blood). This clot model is used
in the mechanical thrombectomy procedure since it mimics aged
cholesterol-rich clot and is prone to fragmentation during
thrombectomy.6 Mixing human blood with thrombin
(2.5 NIHU thrombin/mL blood) formed the soft clot model.
The composition and mechanical behavior of the soft clot
model are similar to those of the fresh red clots commonly
found in patients with stroke.6 In both models a small amount
of barium sulfate (1 g/10 mL blood) was added to create con-
trast necessary for segmentation on CT.
Under ﬂuoroscopic guidance (Allura Xper FD20; Philips,
Best, The Netherlands), the Trevo device (Stryker
Neurovascular, Fremont, California, USA) was placed across the
clot. Immediately following device deployment, a high-
resolution cone beam CT was acquired (VasoCT, Philips). After
waiting for 5 min following device deployment, imaging was
repeated. For each of the two deployment techniques and each
of the two clot models, the experiments were repeated eight
times resulting in a total of 64 imaging datasets.
Image acquisition and processing
VasoCT images (617 non-binned projections, 20.4 s rotation)
were reconstructed at 33% or 50% of the ﬁeld-of-view (24.7–
34.5 mm cube) volume at highest resolution (5123 isotropic
voxels), yielding 48–67 μm resolution.
An image processing pipeline was devised that combines exist-
ing geometric (vascular) modeling software (VMTK,16 ITK,
VTK) with in-house developed software. First, anisotropic diffu-
sion ﬁltering was applied to reduce noise. Thereafter, high-
intensity shortest paths were traced using Dijkstra’s algorithm
along user-deﬁned seed points to extract the three marker wires
of the device. Uniform cubic B-spline curves were ﬁtted to the
extracted paths to obtain smooth wire tracings (ﬁgure 2, second
image). Next, demarcation of the contrast-enhanced clot was
achieved using a threshold-based level-set segmentation algo-
rithm initialized by user-deﬁned seed points near the surface of
the clot and morphological closing was applied to the clot seg-
mentation to ﬁll occasional holes (ﬁgure 2, third image). Along
the three marker wires of the stent, their coordinates were aver-
aged to obtain a device centerline which was subsequently
smoothed and used to calculate a reference Frenet frame at each
point along the centerline. The interior volume of the device
was determined by ﬁtting a Steiner circumellipse through the
three closest wire points that intersected each plane orthogonal
to the Frenet tangent vector at sequential points along the
Figure 1 The circle of Willis model used in this study. Bilateral M2
divisions of the middle cerebral arteries and the A2 segments of the
anterior cerebral arteries were designed to rejoin distally. In all there
were three inputs to the model (red arrows) and four outlets (green
arrows).
Figure 2 From left to right:
Iso-intensity surfaces representing the
device were extracted to guide the
identiﬁcation of individual wires. Seed
points were manually placed to extract
each of the wires (red). Manual seed
points were placed to initialize the
level-set segmentation of the clot
which, after post-processing, was
displayed as a surface model (green).
Along consecutive points on the
centerline, a Steiner circumellipse was
ﬁt to the closest points on the three
marker wires (red) to model the
interior of the device (blue).
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centerline (ﬁgure 2, fourth image). Marching cubes and surface
re-meshing algorithms were applied to the clot and device seg-
mentations in order to extract and reﬁne appropriate surface
model representations for computation of CIF.
CIF was calculated by determining the intersection of the
device and clot volumes and subsequently dividing the volume of
the intersection by the volume of the clot. Separate two-sample
(paired if appropriate) t tests were performed to investigate the
effects of deployment technique and time on CIF for different
clot models. A p value <0.05 was considered signiﬁcant.
Clot fragmentation and distal emboli
As previously described, we measured the particle size distribu-
tion of clot fragments generated during the thrombectomy in
the efﬂuent of the circulation ﬂow loop.17 All emboli
>1000 μm were separated with a pipette and all remaining par-
ticles >200 μm were measured using a Coulter counter
(Multisizer4; Beckman-Coulter, Brea, California, USA) with a
2000 μm aperture. In each experiment, the total number of
clots >200 μm were summed and experimental groups were
compared with an ordinary one-way analysis of variance.
Figure 3 Representative cases in a
hard clot model with different Trevo
deployment techniques (left, straight
unsheathing; right, initial unsheathing
followed by pushing the device and
spontaneous retraction of the
microcatheter). Stent surface shown in
blue, clot surface shown in transparent
green. Insets show cross-sectional
images of the device–clot interaction
at different locations along the length
of the stent. Sharp focal
hyperintensities (arrowhead) are the
device marker wires. Note track of
stent impregnation into the clot
(arrow).
Figure 4 Box plot of the clot
integration factor immediately
following deployment indicating a
signiﬁcant increase as a function of
deployment delivery technique when
the device engaged hard clot
(p<0.05). No signiﬁcant difference was
found in the soft clot model.
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RESULTS
We were able to use this technique to independently segment
the surface of the clot and the stent (ﬁgure 3) and calculate the
CIF in all cases. In all but three experiments, immediate post-
deployment images were available for analysis and ﬁnal post-
deployment data were available for all cases.
First, we investigated the effect of the deployment technique
(pushing vs unsheathing) on CIF for the different clot models
(ﬁgure 4). CIF was signiﬁcantly different for the two deploy-
ment variations when the device engaged hard clot (means:
pushing=0.291, unsheathing=0.202; difference between means
(95% CI 0.004 to 0.174); t=2.25, df=14; p=0.041) (see
online supplementary videos), but not a soft clot model
(means: pushing=0.342, unsheathing=0.359; difference
between means (95% CI −0.138 to 0.104); t=0.31; df=9;
p=0.764). The formation of distal fragments >200 μm did not
depend on the technique of retriever deployment (ﬁgure 5,
p>0.05). Pushing the device and straight unsheathing resulted
in a median of 2.5 and 2 hard clot fragments >200 μm per
case, respectively. Fewer clot fragments were observed with
both techniques in the soft clot model compared with the hard
clot model.
Next, we investigated the effect of time on CIF (post-
deployment vs ﬁnal VasoCT) for the different clot models
(ﬁgure 6). In the hard clot model, CIF increased signiﬁcantly
between post-deployment and ﬁnal imaging datasets when using
the pushing technique (mean difference=0.027 (95% CI 0.006
to 0.047); paired t=3.20, df=6; p=0.019), but not when using
the unsheathing technique (mean difference=0.037 (95% CI
−0.004 to 0.078); paired t=2.23, df=6; p=0.067).
Additionally, there was no signiﬁcant difference between post-
deployment and ﬁnal runs in the soft clot model using pushing
(mean difference=0.053 (95% CI −0.005 to 0.111); paired
t=2.18, df=7; p=0.066) or unsheathing (mean differ-
ence=0.079 (95% CI −0.010 to 0.168); paired t=2.18, df=6;
p=0.072).
We investigated the effect of time on CIF in the different
clot models, disregarding the technique. CIF was signiﬁcantly
increased when measured in the ﬁnal dataset relative to the
post-deployment dataset in both the hard clot model (mean
difference=0.032 (95% CI 0.012 to 0.051); paired t=3.52,
df=13; p=0.004) and in the soft clot model (mean differ-
ence=0.065 (95% CI 0.021 to 0.110); paired t=3.13, df=14;
p=0.007).
Figure 5 Total number of clot fragments >200 μm for each technique
and clot model used.
Figure 6 Box plot of the difference
in clot integration factor between the
post-deployment and ﬁnal runs in the
hard clot and soft clot models showing
the effect of time on clot integration.
Positive values indicate an increase in
clot integration. Outliers are indicated
by black dots. There was a small but
signiﬁcant increase overall for both
models, and a signiﬁcant increase in
the hard clot model for the pushing
but not the unsheathing technique.
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DISCUSSION
Previously, the extent of Solitaire expansion in clinical cases
using cone beam CT was reported to enable qualitative assess-
ment of occlusion type.18 In this study, we quantitatively evalu-
ated the integration of the clot into a stent retriever in a
controlled in vitro experiment. We chose the Trevo device since
it incorporates marker wires into its design that enable us to
model the surface of the device separately from the radiopaque
clot on VasoCT imaging datasets. Also, this device design
(closed-cell, laser cut nitinol tube) allows for expansion of the
diameter when forward force is applied. Given the difference in
contrast between the clot model and the stent, we could then
determine the amount of clot that became enmeshed within the
device by measuring the CIF.
The CIF was dependent on delivery technique used in the
hard inelastic clot model. By pushing the device during deploy-
ment at the level of the clot, more clot integrated within the
Trevo without increasing clot fragmentation and distal embol-
ization. However, in this model, simply unsheathing the device
led to a decrease in CIF. This may help to explain why
pushing the device during delivery is associated with higher
rates of ﬁrst-pass success and TICI 3 results.10 However, the
CIF was independent of the delivery technique in the soft
elastic clot.
Another interesting result was that there was a small but sig-
niﬁcant change in clot integration with the device over time,
especially when pushing the device in a hard clot model.
Nitinol devices exert a chronic outward force, and it is believed
that this force causes the clot to become enmeshed within the
device over time as the stent expands through the clot. We
could not associate delivery technique with signiﬁcant changes
in CIF over time for the soft clot models within the recom-
mended 5 min observation period. However, when delivery
techniques were combined, both soft and hard clot models
showed signiﬁcant increases in CIF over time. Therefore, our
model indicates a potential beneﬁt for waiting following deploy-
ment of the device, in particular in combination with the
pushing technique when engaging a hard clot.
There are several limitations to our study. The clot models
used in this study are manufactured in the laboratory and,
although designed to mimic the bulk mechanical properties of
clinical clot specimens, they are homogenous (unlike clots that
cause stroke).6 Also, our in vitro model uses normal saline as
the working ﬂuid and therefore does not model dynamic fea-
tures of blood, including in situ clot formation or platelet activa-
tion. Furthermore, the pushing technique should be carefully
performed to avoid forward movement or kinking of the
device, which was not observed in any of our experiments.
Extending this approach to different devices and clot models is
highly dependent on the level of contrast-enhanced clot and
radiopaque marker wire visibility and also on the achieved
image contrast between the two. If the stent strut attenuation is
similar to that of the barium sulfate-enriched clot, segmentation
of the device would require additional modeling of its mechan-
ical properties to predict deployment conﬁgurations from
limited observations outside the clot. Finally, this technique is
dependent on device design and can only be used on devices
that expand in response to the forward force. It has been
reported that the Solitaire device deployed with gentle forward
pressure following initial unsheathing is effective in removing
migrated coils.19 Our attempts to measure CIF with the Solitaire
device were not successful due to insufﬁcient contrast differ-
ences between the device and the clot model.
CONCLUSION
We developed a method to quantitatively measure the amount
of clot that integrated with a stent retriever containing radi-
opaque markers. Clot integration was a function of delivery
technique, duration of device implantation, and clot mechanics.
This technique could be used in the design and development of
future generations of stent retrievers.
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